BioSpace News Archive

Clarity Pharmaceuticals, a clinical-stage radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Rare Paediatric Disease Designation (RPDD) to 64 Cu-SARTATE™, a diagnostic for the clinical management of neuroblastoma. Dr Alan Taylor

- Ampion-treated patients showed improvement from severe disease/hospitalization to uninfected/ambulatory on the ordinal scale - Ampion-treated patients showed greater improvement compared to patients treated with the standard of care including anti-viral therapies - Ampion found to be safe and well-tolerated with no drug related adverse events

ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will participate in a virtual fireside chat at the Morgan Stanley 18 th Annual Global Healthcare Conference on Monday, September 14, 2020, beginning at approximately 12:45 p.m. (Eastern Daylight Time) via video webcast.

Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that John A. Scarlett, M.D., Chairman and Chief Executive Officer, will present a company overview at the H.C. Wainwright 22nd Annual Global Investment Conference, to be hosted in a virtual format, on Monday, September 14, 2020 at 2:30 p.m. ET. A live audio webcast of the presentation will be available on Geron’s w

Aegis Life, Inc., the leading developer of the next generation of DNA vaccines and therapies for the world’s most dangerous diseases, announced today that it has appointed its co-founder, Hong Jiang, Ph.D., as its Chief Operating Officer (COO).

Q-CTRL, a startup that applies the principles of control engineering to accelerate the development of quantum technology, and Quantum Machines, creator of the first complete hardware and software solution for the control and operation of quantum computers, today announced a global commercial partnership to integrate Q-CTRL’s firmware into Quantum Machines’ quantum hardware platform.

- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced its participation at two upcoming virtual investor conferences. Michael S. Weiss, the Company’s Executive Chairman and Chief Executive Officer, is scheduled to participate in fireside chats during the following conferences: The H.C. Wainwright 22nd Annual Global Investment Conference – fireside chat scheduled to take place on Monday, September 14, 2020 at 1:30 PM ET The Cantor Fitzgerald Globa

PCT LTD CEO, Gary Grieco, will provide investors with an update on the significant corporate activities and goals that PCT LTD has accomplished as well as plans for the future.

Fountain Therapeutics (“Fountain”), a biopharmaceutical company building a pipeline of therapeutics to treat age-related diseases by reversing cellular age, today announced it has moved its corporate headquarters to Lilly Gateway Labs in South San Francisco upon selection by Eli Lilly and Company.

iotaMotion Inc., an early-stage medical technology startup spun out of the University of Iowa’s Otolaryngology Department, announced today that the company has been awarded a $1.65M grant from the National Institutes of Health (NIH).